Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiaojing Cuyun Pill for thin endometrium-related infertility
ChiCTR2400084571Phase 4Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Tiaojing Cuyun Pill, estradiol valerate and dydrogesterone in female infertility and Endometrial hypotrophy (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Endometrial thickness on ovulation day of the 3rd menstrual cycle. Planned start May 2024; status: not yet recruiting.
02
Drugs
Tiaojing Cuyun Pillestradiol valeratedydrogesterone
03
Conditions
female infertilityEndometrial hypotrophy
Beyond the preview
Go deeper on ChiCTR2400084571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084571.